Much has been written about the role Pharmacy Benefit Managers (PBMs) play in driving up the cost of prescription brand named drugs. However, far less has been written about how PBMs current business practices lead U.S. consumers, employers, and the government to pay too much for what should be low-cost drugs. Now a new paper, […]
The post Study Links PBMs to Medicine Overpayments appeared first on The American Consumer Institute.